Literature DB >> 27864996

Skin microtopography as a measure of photoaging and risk of squamous cell carcinoma of the skin in a US population.

Lawrence Fitzgerald Kuklinski1, Michael Scot Zens1, Ann E Perry2, Adele C Green3,4, Margaret R Karagas1.   

Abstract

BACKGROUND: Skin microtopography as a measure of photoaging is a noninvasive approach to measuring chronic ultraviolet radiation exposure and reflects the degree of dermal elastosis in populations of European descent in the subtropics. Less is known about the utility of this approach in populations at different latitudes, and whether it relates to skin cancer risk.
METHODS: A population-based case-control study of 342 squamous cell carcinoma (SCC) cases and 331 age- and gender-matched controls were evaluated for histologic evidence of solar damage and severity of photoaging based on microtopography on a six-grade scale. Odds ratios (OR) for SCC associated with degree of photoaging were estimated using logistic regression analysis adjusted for potentially confounding factors.
RESULTS: After adjustment for known risk factors, SCC was associated with increasing photoaging grade (OR = 1.7, 95% CI = 0.9-3.0 for severe photoaging; OR = 2.8, 95% CI = 1.6-5.0 for very severe photoaging). Associations remained among those with actinic keratosis (OR = 3.4, 95% CI = 0.9-12.4 for severe photoaging, OR = 5.7, 95% CI = 1.7-19.6 for very severe photoaging). LIMITATIONS: There was limited statistical power, particularly for subgroup analyses.
CONCLUSION: Our findings provide further evidence of microtopography as an independent, objective indicator of risk of SCC.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  microtopography; photoaging; squamous cell carcinoma; ultraviolet radiation

Mesh:

Year:  2017        PMID: 27864996      PMCID: PMC5408582          DOI: 10.1111/phpp.12280

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  38 in total

1.  Pigmentary and cutaneous risk factors for non-melanocytic skin cancer--a case-control study.

Authors:  A Kricker; B K Armstrong; D R English; P J Heenan
Journal:  Int J Cancer       Date:  1991-07-09       Impact factor: 7.396

2.  Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans.

Authors:  E F Bernstein; C B Underhill; P J Hahn; D B Brown; J Uitto
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

Review 3.  Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Chiho Muranushi; Catherine M Olsen; Nirmala Pandeya; Adèle C Green
Journal:  J Invest Dermatol       Date:  2014-12-18       Impact factor: 8.551

4.  Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma.

Authors:  Maryam M Asgari; Mary-Margaret Chren; E Margaret Warton; Gary D Friedman; Emily White
Journal:  Arch Dermatol       Date:  2010-02-15

Review 5.  Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Authors:  Tracy Wolff; Eric Tai; Therese Miller
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

6.  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

7.  Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Authors:  Craig A Elmets; Jaye L Viner; Alice P Pentland; Wendy Cantrell; Hui-Yi Lin; Howard Bailey; Sewon Kang; Kenneth G Linden; Michael Heffernan; Madeleine Duvic; Ellen Richmond; Boni E Elewski; Asad Umar; Walter Bell; Gary B Gordon
Journal:  J Natl Cancer Inst       Date:  2010-11-29       Impact factor: 13.506

8.  Reduction of fibroblast size/mechanical force down-regulates TGF-β type II receptor: implications for human skin aging.

Authors:  Gary J Fisher; Yuan Shao; Tianyuan He; Zhaoping Qin; Daniel Perry; John J Voorhees; Taihao Quan
Journal:  Aging Cell       Date:  2015-10-08       Impact factor: 9.304

9.  Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.

Authors:  Sarah N Robinson; Michael S Zens; Ann E Perry; Steven K Spencer; Eric J Duell; Margaret R Karagas
Journal:  J Invest Dermatol       Date:  2013-01-23       Impact factor: 8.551

10.  Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study.

Authors:  A Ø Jensen; H F Thomsen; M C Engebjerg; A B Olesen; H T Sørensen; M R Karagas
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more
  3 in total

1.  Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study.

Authors:  Rossybelle P Amorrortu; Neil A Fenske; Basil S Cherpelis; Laxmi Vijayan; Yayi Zhao; Juliana Balliu; Jane L Messina; Vernon K Sondak; Anna R Giuliano; Tim Waterboer; Michael Pawlita; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-19       Impact factor: 4.254

2.  Circulating Immunosuppressive Regulatory T Cells Predict Risk of Incident Cutaneous Squamous Cell Carcinoma.

Authors:  Dana E Rollison; Jane L Messina; Basil S Cherpelis; Neil A Fenske; Michael J Schell; Dennis O Adeegbe; Yayi Zhao; Rossybelle P Amorrortu; Afua A Akuffo; Rebecca S Hesterberg; Pearlie K Epling-Burnette
Journal:  Front Med (Lausanne)       Date:  2021-11-02

3.  Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas.

Authors:  Dana E Rollison; Rossybelle P Amorrortu; Yayi Zhao; Jane L Messina; Michael J Schell; Neil A Fenske; Basil S Cherpelis; Anna R Giuliano; Vernon K Sondak; Michael Pawlita; Sandrine McKay-Chopin; Tarik Gheit; Tim Waterboer; Massimo Tommasino
Journal:  Cancer Res       Date:  2021-07-15       Impact factor: 12.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.